The first healthy volunteer has been dosed with Imperial College London’s coronavirus vaccine, the second UK-developed candidate to reach the clinical testing stage.
Bristol Myers-Squibb and digital health firm GRYT Health have teamed up to develop an ‘Advocacy Exchange’ virtual platform to unite patient advocacy organisations, patients, policy makers,
Charities have already been hit hard by the coronavirus pandemic and lockdown, and Cancer Research UK says it could have to cut £150 million from much-needed research funding a
GlaxoSmithKline has begun a COVID-19 clinical trial with China’s Clover Biopharmaceuticals, combining its booster with the biotech’s early-stage vaccine.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.